Medications can do wonders for cancer, but they can also be harmful. This is why it’s important to weigh your options and talk to your doctor before taking any supplements or alternative medicines, especially if you have a serious health condition like a cancer.
Stanford researchers have been testing an experimental drug called fenbendazole, or Panacur C, to see if it can shrink tumors and prevent them from growing. The drug targets the cellular mechanisms that viruses and some cancer cells use to grow and spread. If successful, it could eventually be used to treat a wide range of diseases and conditions.
The team, led by Stanford professors of medicine and of microbiology and immunology, published their findings Jan. 22 in Science Translational Medicine. The research was supported by the National Institutes of Health and the National Cancer Institute.
In a previous study, the researchers found that fenbendazole inhibits the proliferation of colorectal cancer (CRC) cells by blocking tubulin polymerization, thereby inducing mitotic catastrophe and triggering apoptosis. In the new study, they wanted to test whether the molecule’s anti-cancer properties also require p53.
To investigate this, they conducted focus group interviews with 21 lung cancer patients. The interviews were based on a semi-structured questionnaire that covered three categories: the information acquisition process of fenbendazole and general cancer information, the quality of obtained information, and the perceptions toward this information. The participants were 13 men and eight women aged 56 to 75 years. fenbendazole for cancer
+ There are no comments
Add yours